Cost and effectiveness evaluation of prophylactic HPV vaccine in developing countries.


BACKGROUND Approximately 80% of cervical cancer cases occur in developing countries. In Thailand, cervical cancer has been the leading cancer in females, with an incidence of 24.7 cases per 100,000 individuals per year. OBJECTIVES We constructed a decision model to simulate the lifetime economic impact for women in the context of human papillomavirus (HPV… (More)
DOI: 10.1016/j.jval.2011.11.007


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics